Arvind singh

🆕 Review: Finerenone with Empagliflozin in CKD with diabetes (CONFIDENCE): Only a blood pressure effect? Likely! doi.org/10.1093/ndt/gf…

We are pleased to announce GlomCon Europe 2026, scheduled for 16-17 April 2026 at the Altis Grand Hotel in Lisbon, Portugal. Join us for a gathering of clinicians, scientists, and educators from around the world on all things glomerular diseases. Learn more: glomcon.org/glomconeurope2… #GlomCon #GlomConEurope2026

Absolutely

NEW Chapter 👉Minimal Change Disease at glompedia.org Minimal Change Disease is a podocytopathy appearing normal on light microscopy and immunofluorescence. Electron microscopy reveals the diagnostic feature: diffuse podocyte foot process effacement. Read more: bit.ly/MinimalChangeD… #GlomPedia #GlomCon #MinimalChangeDisease

The Optimize Study was presented today at #KidneyWk Good to know (at least in the elderly), Tac target levels of 1.5 to 4 after 6 mths is enough. We strive to keep it above 5 usually... CC @sundar_s1955 journals.lww.com/jasn/fulltext/…

No benefit from beta-blockers in patients with recent myocardial infarction and LVEF equal or greater than 50%. #AHA2025 IPD meta-analysis of 5 RCTs including 17,801 patients (REBOOT, REDUCE-AMI, BETAMI, DANBLOCK, and CAPITAL-RCT). @Borjaibanez1 @dan_atar @RosselloXavier @evaprescott @drjohnm @mmamas1973 @djc795 @mirvatalasnag @EAPCIPresident @SABOURETCardio @Hragy @kaulcsmc @EricSecemskyMD @venkmurthy @DrMarthaGulati @SripalBangalore @sbrugaletta @DLBHATTMD @EricTopol @CMichaelGibson @DFCapodanno @nadig_cardio @Ortega_Paz @HadyLichaaMD @ACCinTouch @Medscape @AHAScience Published on @NEJM nejm.org/doi/full/10.10…

@priti899 @arvindcanchi @AnnaGaddy @kdjhaveri @govil_amit @Arunkr_Dr @NephroSeeker @brian_rifkin @jmteakell Excellent visual abstract Priti

🚨 New Trial Alert! Atacicept shows a significant reduction in proteinuria in IgAN at 36 wks. Fresh from #NEJM and highlighted for #KidneyWeek! 📊🧬🩺nejm.org/doi/full/10.10…

Happy to see our review on "challenges" in ANCA-associated vasculitis published in @NatRevRheumatol! A special thanks to the Editorial Team and also @martacasalmoura for leading this initiative! #vasculitis @EUVAS19 @vasculitides

Kicking off the PKD Medical Directorship Program 🌟 Our first session was a success, starting strong with a fascinating presentation from Dr. Pranav Garimella @pranavgarimella Followed by interactive insightful case discussions presented by three talented fellows: Dr. Sol Maria Carriazo Julio @Nefrontera, Dr. Sandra Karanovic Stambuk @sandra_k910 and Dr. Mohamed Hassanein @kidneymo #Glomcon #PKDMDP

> When to do genetic testing ?

> Ultrasound & MRI by age group criteria has pretty good predictive value.

Kicking off with our ADPKD fellowship session in style with @pranavgarimella & @SaynaNorouzi @GlomCon. Brilliant comprehensive talk by Dr Garimella. Special thanks to @MarietheresebouAuntoun for sending some valuable articles our way.

We’re back! 🎉 @GlosRenal & @GlosPgme present the 3rd Annual Gloucestershire Renal Education Day — 27 Nov 2025. Humbled by your feedback last year — and ready for more learning & collaboration! Spaces going fast ⏰ #RenalEducation💙 #MedEd

@SaynaNorouzi @VladoPerkovic @poyanmehr @BetterCallSeeth @nephrologista This has been much discussed at various platforms of renal & glomerular diseases and I think it’s time when we seriously consider redesigning clinical trials specially when we have decades of data on natural history of these so called rare diseases.

Should we design IgA nephropathy clinical trials in a different way? @VladoPerkovic sharing new ideas in the clinical trials landscape #GlomConHawaii

How to approach to FSGS by Dr. Fervenza @GlomCon #GlomConHawaii

@zainabo87 @DuvuruG @Momen_Abbasi Excellent work @zainabo87 🙏

Read our IgAN editorial on KidneyNews today!✨#IgAN #Glomerulardisease kidneynews.org/downloadpdf/vi…

@SaynaNorouzi @GlomCon Whose jealous ?? I am surely not 😭😭😭

Excited @GlomCon #GlomConHawaii

Today, we begin another year of working and learning together with the @GlomCon Foundation Glomerular Disease Fellowship Program. Every year, it is an honor to welcome and train ~ 170 fellows. Deeply grateful for the opportunit and I’m really proud of the impact we’re making together. #GlomerularDisease #Genetic #Rare #Nephrology #Fellowship #Education

@priti899 @kidneymedicine @kdjhaveri @SaynaNorouzi @ISGDtweets @drmanishasahay @raja_1980 @nephrologista @AKronbichler @BetterCallSeeth @poyanmehr Excellent stuff. Well done Priti and team 👏🏼👏🏼

🚨 🤝 Excited to share that we collaborated 🌎 and present one of the largest cohorts ever – 126 FGN pts. clinical features & outcomes from the Indian cohort IN Kidney Medicine.🇮🇳 @kidneymedicine Have a read! share.google/vXkC7LqPNFKtWo… 🙏 Huge thanks to the entire team for making this possible!